CareLit Fachartikel

High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington di…

PM Meyer, ID Grachev, GA Becker, M Bronzel, D Marsteller, O Voges, L Rabinovich, F Zientek, M Rullmann, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, H Barthel, M Hayden, O Sabri · Nuklearmedizin - NuclearMedicine · 2020 · Heft 02

Dokument
1214699
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
PM Meyer, ID Grachev, GA Becker, M Bronzel, D Marsteller, O Voges, L Rabinovich, F Zientek, M Rullmann, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, H Barthel, M Hayden, O Sabri
Ausgabe
Heft 02 / 2020
Jahrgang 59
Seiten
–
Erschienen: 2020-04-01 00:00:00
ISSN
0029-5566
DOI
10.1055/s-0040-1708168

Zusammenfassung

High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride PET study

Schlagworte

Receptor Dopamine Sigma-1 Occupancy Clinically Relevant Doses Pridopidine Healthy Volunteers Huntington Disease Nuklearmedizin - NuclearMedicine